Precision Optics (POCI) Set to Announce Quarterly Earnings on Thursday

Precision Optics (NASDAQ:POCI) will likely be announcing its Q1 2027 results after the market closes on Thursday, November 12th. Analysts expect Precision Optics to announce earnings of ($0.13) per share and revenue of $6.40 million for the quarter. Investors may visit the company’s upcoming Q1 2027 earnings results page for the latest details on the call scheduled for Thursday, November 12, 2026 at 5:00 PM ET.

Precision Optics (NASDAQ:POCI) last posted its quarterly earnings data on Monday, September 28th. The company reported ($0.01) earnings per share for the quarter, beating the consensus estimate of ($0.06) by $0.05. The business had revenue of $8.77 million during the quarter, compared to the consensus estimate of $7.10 million. Precision Optics had a negative return on equity of 23.92% and a negative net margin of 11.51%.

Precision Optics Stock Performance

Shares of POCI opened at $4.84 on Thursday. The company’s 50 day simple moving average is $4.44 and its 200-day simple moving average is $4.63. The firm has a market cap of $53.19 million, a PE ratio of -10.52 and a beta of 0.23. Precision Optics has a 12-month low of $3.55 and a 12-month high of $6.15. The company has a current ratio of 2.28, a quick ratio of 1.84 and a debt-to-equity ratio of 0.03.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. Wall Street Zen upgraded shares of Precision Optics to a “hold” rating in a research note on Saturday, October 3rd. Weiss Ratings restated a “sell (d-)” rating on shares of Precision Optics in a research note on Wednesday, September 2nd. One research analyst has rated the stock with a Sell rating. Based on data from MarketBeat, the stock has a consensus rating of “Sell”.

About Precision Optics

Precision Optics Corporation, Inc is a medical technology company that develops and manufactures advanced optical systems and components for minimally invasive medical procedures. The company works primarily with medical device manufacturers, providing specialized imaging technologies designed to support visualization during surgery and other clinical applications.

Its product portfolio includes rigid and flexible endoscopes, three-dimensional endoscopic systems, disposable and reusable visualization devices, surgical cameras, and custom optical assemblies.